Methods for synthesizing mevalonate
View Patent ↗Methods for synthesizing isopentenyl pyrophosphate are provided. A first method comprises introducing into a host microorganism a plurality of heterologous nucleic acid sequences, each coding for a different enzyme in the mevalonate pathway for producing isopentenyl pyrophosphate. A related method comprises introducing into a host microorganism an intermediate in the mevalonate pathway and at least one heterologous nucleic acid sequence, each sequence coding for an enzyme in the mevalonate pathway necessary for converting the intermediate into isopentenyl pyrophosphate. The invention also provides nucleic acid sequences, enzymes, expression vectors, and transformed host cells for carrying out the methods.
1. A method for synthesizing mevalonate via a mevalonate pathway in a host cell, wherein the method comprises:
i) culturing a transformed host cell in a suitable medium, wherein the transformed host cell is a prokaryote that does not normally synthesize isopentenyl pyrophosphate (IPP) through the mevalonate pathway, and wherein the host cell comprises one or more nucleic acids heterologous to the host cell, wherein the one or more heterologous nucleic acids comprises nucleotide sequences that encode:
(a) a eukaryotic enzyme that condenses two molecules of acetyl-CoA to acetoacetyl-CoA;
(b) a eukaryotic enzyme that condenses acetoacetyl-CoA with acetyl-CoA to form HMG-CoA; and
(c) a eukaryotic enzyme that converts HMG-CoA to mevalonate;
wherein the host cell is not transformed with a heterologous nucleic acid comprising a nucleotide sequence encoding an enzyme that converts mevalonate into mevalonate 5-phosphate,
said culturing providing for production of the enzymes, resulting in synthesis of said mevalonate by the transformed host cell.
2. The method of claim 1 , wherein the one or more heterologous nucleic acids is integrated into the chromosome of the transformed host cell.
3. The method of claim 1 , wherein the one or more heterologous nucleic acids is contained in at least one extrachromosomal expression vector.
4. The method of claim 1 , wherein the one or more heterologous nucleic acids is present in a single expression vector.
5. The method of claim 1 , wherein the enzyme that condenses two molecules of acetyl-CoA to acetoacetyl-CoA is an acetoacetyl-CoA thiolase.
6. The method of claim 1 , wherein the nucleotide sequence encoding the enzyme that condenses acetoacetyl-CoA with acetyl-CoA to form HMG-CoA comprises the nucleotide sequence set forth in SEQ ID NO:2.
7. The method of claim 1 , wherein the nucleotide sequence encoding the enzyme that converts HMG-CoA to mevalonate comprises the nucleotide sequence set forth in SEQ ID NO:3.
8. The method of claim 1 , wherein the transformed host cell is of a genus selected from Escherichia, Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Kiebsiella, Proteus, Salmonella, Serratia, Shigella, Rhizobia, Vitreoscilla , and Paracoccus.
9. The method of claim 1 , wherein the transformed host cell is of the genus Escherichia.
10. The method of claim 1 , wherein the transformed host cell is an Escherichia coli.
11. The method of claim 1 , wherein the transformed host cell is of the genus Enterobacter.
12. The method of claim 1 , wherein the transformed host cell is of the genus Erwinia.
13. The method of claim 1 , wherein the transformed host cell is of the genus Bacillus.
14. The method of claim 1 , wherein the transformed host cell is of the genus Proteus.
15. The method of claim 1 , wherein the transformed host cell is of the genus Rhizobia.
16. The method of claim 1 , wherein the transformed host cell is of the genus Paracoccus.
17. A method for synthesizing mevalonate via a mevalonate pathway in a host cell, wherein the method comprises:
i) culturing a transformed host cell in a suitable medium, wherein the transformed host cell is Escherichia coli , and wherein the host cell comprises one or more nucleic acids heterologous to the host cell, wherein the one or more heterologous nucleic acids comprises nucleotide sequences that encode:
(a) a eukaryotic enzyme that condenses two molecules of acetyl-CoA to acetoacetyl-CoA;
(b) a eukaryotic enzyme that condenses acetoacetyl-CoA with acetyl-CoA to form HMG-CoA; and
(c) a eukaryotic enzyme that converts HMG-CoA to mevalonate;
wherein the host cell is not transformed with a heterologous nucleic acid comprising a nucleotide sequence encoding an enzyme that converts mevalonate into mevalonate 5-phosphate,
said culturing providing for production of the enzymes, resulting in synthesis of said mevalonate by the transformed host cell.
18. The method of claim 17 , wherein the one or more heterologous nucleic acids is integrated into the chromosome of the transformed host cell.
19. The method of claim 17 , wherein the one or more heterologous nucleic acids is contained in at least one extrachromosomal expression vector.
20. The method of claim 17 , wherein the one or more heterologous nucleic acids is present in a single expression vector.
21. The method of claim 17 , wherein the enzyme that condenses two molecules of acetyl-CoA to acetoacetyl-CoA is an acetoacetyl-CoA thiolase.
22. The method of claim 17 , wherein the nucleotide sequence encoding the enzyme that condenses acetoacetyl-CoA with acetyl-CoA to form HMG-CoA comprises the nucleotide sequence set forth in SEQ ID NO:2.
23. The method of claim 17 , wherein the nucleotide sequence encoding the enzyme that converts HMG-CoA to mevalonate comprises the nucleotide sequence set forth in SEQ ID NO:3.